Brief: Transgene FY Operating Income EUR -35.1 Million
24/03/2026 16:45
Mar 24 (Reuters) - Transgene FY revenue EUR 7.2 million. FY operating expenses EUR 42.3 million FY net income EUR -37.5 million
Recent news on Transgene SA
See all newsBrief: Transgene & NEC Bio Sign License Agreement To Prepare Next Steps Of Development Of TG4050 In Head & Neck Cancer
Brief: Transgene SA Says Myvac Platform To Initiate Phase 1 Trial In Second Indication In 2026
France's Transgene 2025 net loss widens on higher financial costs
Brief: Transgene FY Operating Income EUR -35.1 Million
Brief: Euronext: Quarterly Review Of CAC Family